ResearcherUniversity of Massachusetts BostonActive in the last 2 years
Vida Karimnia
Matched on ORCID iD 0000-0001-9086-3077; OpenAlex author ID A5001110260. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2021: 2 papers · 2022: none · 2023: 1 paper · 2024: 1 paper
Papers 4
- Drug resistant pancreatic cancer cells exhibit altered biophysical interactions with stromal fibroblasts in imaging studies of 3D co-culture models. Co-author DOI 10.1038/s41598-024-71372-9↗
- Photodynamic Stromal Depletion Enhances Therapeutic Nanoparticle Delivery in 3D Pancreatic Ductal Adenocarcinoma Tumor Models. Co-author DOI 10.1111/php.13663↗
- Photodestruction of Stromal Fibroblasts Enhances Tumor Response to PDT in 3D Pancreatic Cancer Coculture Models. Co-author DOI 10.1111/php.13339↗
- Photodynamic Therapy for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers13174354↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jonathan P. Celli · 4 shared papers, 2021–2024 · strength 0.85
- Paper Photodynamic Therapy for Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers13174354↗
- Paper Photodynamic Stromal Depletion Enhances Therapeutic Nanoparticle Delivery in 3D Pancreatic Ductal Adenocarcinoma Tumor … DOI 10.1111/php.13663↗
- Paper Drug resistant pancreatic cancer cells exhibit altered biophysical interactions with stromal fibroblasts in imaging stu… DOI 10.1038/s41598-024-71372-9↗
- Frank J. Slack · 4 shared papers, 2021–2024 · strength 0.85
- Paper Photodynamic Therapy for Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers13174354↗
- Paper Photodynamic Stromal Depletion Enhances Therapeutic Nanoparticle Delivery in 3D Pancreatic Ductal Adenocarcinoma Tumor … DOI 10.1111/php.13663↗
- Paper Drug resistant pancreatic cancer cells exhibit altered biophysical interactions with stromal fibroblasts in imaging stu… DOI 10.1038/s41598-024-71372-9↗
- Eric Struth · 1 shared paper, 2024 · strength 0.22
- Gwendolyn M. Cramer · 1 shared paper, 2024 · strength 0.22
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.